Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals

Xiaodong YANG; Xiuwen WANG; Xin ZHANG; Haifeng DING; Hu WANG; Tao HUANG; Guanghui ZHANG; Junyi DUAN; Wei XIA; Bin SU; Cong JIN; Hao WU; Tong ZHANG.
Chinese Medical Journal ; (24): 2948-2959, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007725

Documentos relacionados

  1. Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals.
  2. Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.
  3. Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials.
  4. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.
  5. The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis.
  6. Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience.
  7. Variants of SARS-CoV-2: Influences on the Vaccines' Effectiveness and Possible Strategies to Overcome Their Consequences.
  8. T Cell Responses to SARS-CoV-2.
  9. Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
  10. Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review.